Science Explorer Back to mapMap
Discussion
Company · Stony Brook · United States

NeoMatrix Therapeutics (United States)

neomatrixtx.comROR OpenAlex
Research works
1
▼ 18% vs 2018-21
Citations
4
3.2 per fractional work
Top-10% rate
4.8%
all institutions 10.0%
Open access
6%
world 40%
International
6%
world 18%
NeoMatrix Therapeutics (United States)

Not ranked overall: NeoMatrix Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does NeoMatrix Therapeutics (United States) work in?

In all years, 75% of research at NeoMatrix Therapeutics (United States) is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (75%), Biochemistry, Genetics and Molecular Biology (17%), Materials Science (8%).

Health Sciences: 1 fractional works · 75.0% of its workMedicine: 1 fractional works · 75.0% of its workLife Sciences: 0 fractional works · 16.7% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 16.7% of its workPhysical Sciences: 0 fractional works · 8.3% of its workMaterials Science: 0 fractional works · 8.3% of its workALL ITS WORKNeoMatrixTherapeutics…1fractional works, all years
Life Sciences17%Physical Sciences8%Health Sciences75%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 3 fields, with their numbers
    1. Medicine175.0%
    1. Biochemistry, Genetics and Molecular Biology016.7%
    1. Materials Science08.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from NeoMatrix Therapeutics (United States)?

The most cited paper from NeoMatrix Therapeutics (United States) is "Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition" (Lucia Lione, Erika Salvatori, Adriana Petrazzuolo et al., 2021), with 27 citations. Next come "Fibronectin‐derived Epiviosamines enhance PDGF‐BB‐stimulated human dermal fibroblast migrationin vitroand granulation tissue formation in vivo" (7) and "Engineered Fibronectin Peptide Resists Elastase Digestion, Speeds Healing, and Attenuates Scarring in Porcine Burns" (4).

Most cited papers
#PaperReleasedCitations
1 Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition Lucia Lione, Erika Salvatori, Adriana Petrazzuolo et al. · OncoImmunology Open access 2021 27
2 Fibronectin‐derived Epiviosamines enhance PDGF‐BB‐stimulated human dermal fibroblast migrationin vitroand granulation tissue formation in vivo Atulya Prasad, Fubao Lin, Richard A.F. Clark · Wound Repair and Regeneration 20 Jun 2019 7
3 Engineered Fibronectin Peptide Resists Elastase Digestion, Speeds Healing, and Attenuates Scarring in Porcine Burns Fubao Lin, Atulya Prasad, Samantha Weber‐Fishkin et al. · Journal of Investigative Dermatology Open access 26 Dec 2019 4
4 ArF Excimer Laser Debridement of Burn Wounds Promotes Healing Michael C. Musillo, Anders H. Carlsson, Atulya Prasad et al. · Frontiers in Optics + Laser Science 2022 (FIO, LS) Conference paper 2022 0
All 4 most cited papers, with filters and sorting

Which research topics does NeoMatrix Therapeutics (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, vaccines and immunoinformatics approaches, Monoclonal and Polyclonal Antibodies Research and Dermatologic Treatments and Research.

CAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksvaccines and immunoinfor…0vaccines and immunoinformatics approaches: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksDermatologic Treatments …0Dermatologic Treatments and Research: 0 fractional worksWound Healing and Treatm…0Wound Healing and Treatments: 0 fractional worksLaser Applications in Dentistry and Medicine: 0 fractional works
OncologyMolecular BiologyRadiology, Nuclear Medicine and ImagingDermatology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 0 works
  2. 2 vaccines and immunoinformatics approaches Molecular Biology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Dermatologic Treatments and Research Dermatology 0 works
  5. 5 Wound Healing and Treatments Rehabilitation 0 works
  6. 6 Laser Applications in Dentistry and Medicine Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available5.8%not open94.2%

World: 40% of research is openly available.

with international co-authors5.8%domestic only94.2%

World: 18% is written across borders.

How has NeoMatrix Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 18% lower than in 2018-2021.

still counting20202025

Other research institutions in Stony Brook

All research institutions in Stony Brook

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about NeoMatrix Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.